Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.35 |
| ▸ | PNMT | P11086 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.33 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4322724 | 0.92 | AKR1C1 (0.38) | MEN1CYP2C9KMT2AAKR1C1OPRM1 | |
| SCHEMBL1313846 | 0.92 | AKR1C1 (0.42) | AKR1C1HDAC4GAAMCOLN3DPP4 | |
| SCHEMBL26916818 | 0.90 | AKR1C1 (0.41) | MEN1KMT2AAKR1C1OPRM1HDAC4 | |
| SCHEMBL5172372 | 0.87 | OPRM1 (0.50) | MEN1CYP2C9KMT2AOPRM1 | |
| SCHEMBL11079809 | 0.87 | MEN1 (0.53) | MEN1CYP2C9KMT2AAKR1C1OPRM1 | |
| SCHEMBL23248029 | 0.87 | ALDH1A1 (0.39) | MEN1CYP2C9KMT2AGAA | |
| SCHEMBL736092 | 0.86 | POLB (0.39) | MEN1CYP2C9KMT2AABCC8KCNJ11 | |
| SCHEMBL10936488 | 0.85 | AKR1C1 (0.38) | MEN1KMT2AAKR1C1OPRM1HDAC4 | |
| Ethylene SCHEMBL11091539 | 0.84 | MEN1 (0.50) | MEN1CYP2C9KMT2AAKR1C1GAA | |
| SCHEMBL26916732 | 0.82 | KEAP1 (0.32) | MEN1CYP2C9KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7674842-B2 | Phase change inks containing curable isocyanate-derived compounds and phase change inducing components | XEROX CORPORATION (US) | 2010-03-09 | — | — | US | claimed |
| US-7541406-B2 | Phase change inks containing curable isocyanate-derived compounds | XEROX CORPORATION (US) | 2009-06-02 | — | — | US | claimed |
| US-20070123642-A1 | Phase change inks containing curable isocyanate-derived compounds | XEROX CORPORATION | 2007-05-31 | — | — | US | claimed |
| US-20070120909-A1 | Phase change inks containing curable isocyanate-derived compounds and phase change inducing components | XEROX CORPORATION | 2007-05-31 | — | — | US | claimed |
| EP-0179254-B1 | 4,5-Dihydro-4-oxo-2- [(2-trans-phenylcyclopropyl)amino]-3-furancarboxylic acids and derivatives thereof | PENNWALT CORPORATION (US) | 1989-03-29 | — | — | EP | claimed |
| EP-0237028-A1 | N-(phenyl) or n-(phenylcyclopropyl)-2,5-dihydro-2-oxo-4, (substituted phenyl) amino-3-furancarboxamide derivatives | PENNWALT CORPORATION (US) | 1987-09-16 | — | — | EP | claimed |
| US-20250313574-A1 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2025-10-09 | — | — | US | disclosed |
| EP-4536653-A2 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | Eisai R&D Management Co., Ltd. (JP) | 2025-04-16 | — | — | EP | disclosed |
| WO-2023239906-A2 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2023-12-14 | — | — | WO | disclosed |
| US-6998390-B2 | Oxolide antibacterials | ABBVIE INC. | 2006-02-14 | — | — | US | disclosed |
| EP-1579864-A1 | Oxolide antibacterials | ABBOTT LABORATORIES (US) | 2005-09-28 | — | — | EP | disclosed |
| EP-1499326-A1 | OXOLIDE ANTIBACTERIALS | Abbott Laboratories (US) | 2005-01-26 | — | — | EP | disclosed |
| US-20040014688-A1 | Oxolide antibacterials | ABBVIE INC. | 2004-01-22 | — | — | US | disclosed |
| WO-2003090760-A1 | OXOLIDE ANTIBACTERIALS | ABBOTT LABORATORIES (US) | 2003-11-06 | — | — | WO | disclosed |
| EP-0179254-B1 | 4,5-Dihydro-4-oxo-2- [(2-trans-phenylcyclopropyl)amino]-3-furancarboxylic acids and derivatives thereof | PENNWALT CORPORATION (US) | 1989-03-29 | — | — | EP | disclosed |
| US-4614810-A | MICROBIOCIDES | PENNWALT CORPORATION (US) | 1986-09-30 | — | — | US | disclosed |
| EP-0179254-A1 | 4,5-Dihydro-4-oxo-2- [(2-trans-phenylcyclopropyl)amino]-3-furancarboxylic acids and derivatives thereof | PENNWALT CORPORATION (US) | 1986-04-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250313574-A1 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | NEU1, NEU2, NEU4 | MEN1 1124/4885CYP2C9 2725/4885KMT2A 3804/4885 |
| US-20040014688-A1 | Oxolide antibacterials | OGFOD1, PGLS, OXER1 | MEN1 1879/4885CYP2C9 48/4885KMT2A 4588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.